Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:1806-1812

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clyman, R. I.
Right arrow Articles by Roman, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clyman, R. I.
Right arrow Articles by Roman, C.
Related Collections
Right arrow Remodeling
Right arrow Angiogenesis
Right arrow Animal models of human disease
Right arrow Other arteriosclerosis
Right arrow Growth factors/cytokines
Right arrow Ischemic biology - basic studies
Right arrow Pulmonary biology and circulation
Right arrow Smooth muscle proliferation and differentiation
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Other Vascular biology

(Circulation. 2001;103:1806.)
© 2001 American Heart Association, Inc.


Basic Science Reports

In Utero Remodeling of the Fetal Lamb Ductus Arteriosus

The Role of Antenatal Indomethacin and Avascular Zone Thickness on Vasa Vasorum Proliferation, Neointima Formation, and Cell Death

Ronald I. Clyman, MD; Yao Qi Chen, MS; Sylvain Chemtob, MD, PhD; Françoise Mauray, BS; Thomas Kohl, MD; Daya R. Varma, MD, PhD; Christine Roman, BS

From the Cardiovascular Research Institute (R.I.C., Y.Q.C., F.M., T.K., C.R.) and Department of Pediatrics (R.I.C., T.K.), University of California, San Francisco; and the Research Center, Hôpital Sainte-Justine (S.C.), and Department of Pharmacology, McGill University (S.C., D.R.V.), Montreal, Québec, Canada.

Correspondence to Ronald I. Clyman, MD, Box 0544, HSE 1492, University of California, San Francisco, San Francisco, CA 94143-0544. E-mail ric{at}itsa.ucsf.edu

Background—The ductus arteriosus (DA) of newborn infants exposed in utero to indomethacin is resistant to postnatal indomethacin; we hypothesized that this is due to ductus constriction in utero, with subsequent remodeling of the vessel.

Methods and Results—Infusion of fetal lambs with indomethacin for 48 hours constricted the DA and increased the thickness of the avascular zone of the DA, which in turn induced the expression of vascular endothelial growth factor, endothelial nitric oxide synthase (due to ingrowth of vasa vasorum), neointima formation, and loss of smooth muscle cells; moderate degrees of DA constriction in utero increased NO production, which inhibited DA contractility. Marked degrees of DA constriction decreased tissue distensibility and contractile capacity.

Conclusions—DA patency is no longer controlled primarily by prostaglandins once it has been exposed to indomethacin in utero.


Key Words: nitric oxide synthase • prostaglandins • endothelium-derived factors • nitric oxide • pregnancy




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Reese, J. D. Anderson, N. Brown, C. Roman, and R. I. Clyman
Inhibition of cyclooxygenase isoforms in late- but not midgestation decreases contractility of the ductus arteriosus and prevents postnatal closure in mice
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1717 - 1723.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Richard, J. Gao, B. LaFleur, B. W. Christman, J. Anderson, N. Brown, and J. Reese
Patency of the preterm fetal ductus arteriosus is regulated by endothelial nitric oxide synthase and is independent of vasa vasorum in the mouse
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R652 - R660.
[Abstract] [Full Text] [PDF]


Home page
NeoReviewsHome page
M. Narayanan-Sankar and R. I. Clyman
Pharmacology Review: Pharmacologic Closure of Patent Ductus Arteriosus in the Neonate
NeoReviews, August 1, 2003; 4(8): e215 - 221.
[Full Text] [PDF]


Home page
PediatricsHome page
D. Quinn, B. Cooper, and R. I. Clyman
Factors Associated With Permanent Closure of the Ductus Arteriosus: A Role for Prolonged Indomethacin Therapy
Pediatrics, July 1, 2002; 110(1): e10 - 10.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. H. Goldbarg, Y. Takahashi, C. Cruz, H. Kajino, C. Roman, B. M. Liu, Y. Q. Chen, F. Mauray, and R. I. Clyman
In utero indomethacin alters O2 delivery to the fetal ductus arteriosus: implications for postnatal patency
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R184 - R190.
[Abstract] [Full Text] [PDF]